Latest Hodgkin's lymphoma Stories
CAMBRIDGE, Mass., June 10, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.
Public Healthcare Systems in Brazil and Mexico Cover Targeted Therapies but with Indication-Specific Restrictions, According to Findings from Decision Resources Group BURLINGTON, Mass., June
Transparency Market Research added a new report "Global Natural Killer Cell Lymphomas Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
- Data include results from two Phase I studies of ABT-199/GDC-0199 in relapsed/refractory chronic lymphocytic leukemia (CLL) and various subtypes of non-Hodgkin's lymphoma (NHL) NORTH
WHITE PLAINS, N.Y., May 19, 2014 /PRNewswire-USNewswire/ -- Foundation Beyond Belief (FBB), a team of atheists, humanists and religious allies, just completed their second year with The Leukemia
Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., May 15, 2014 /PRNewswire-iReach/ -- In his new book,
Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., April 29, 2014 /PRNewswire-iReach/ -- In his new book,
- First and Only Approved Monotherapy in the EU for this Patient Population - BIRMINGHAM, England, April 29, 2014 /PRNewswire/ -- Cell Therapeutics, Inc.
Patent covers methods of use for small molecule inhibitors in the treatment of NHL, including follicular and diffuse large B-cell lymphomas CAMBRIDGE, Mass., April 24, 2014 /PRNewswire-USNewswire/
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.